Journal of Oncology Case Reports | Volume 2, Issue 1 | Case Report | Open Access

Ovarian Sclerosing Stromal Tumor, Incidental Discovery in a 26-Year-Old Female with a History of Amenorrhea

Khalid Al-Sindi*

1Department of Pathology, King Hamad University Hospital, Bahrain

2Consultant Gynecologist & Laparoscopic Surgeon, Al Salam Specialist Hospital, Bahrain

*Correspondence to: Khalid Al-Sindi 

Fulltext PDF

Abstract

1.1. Introduction: Sclerosing Stromal Tumor (SST) is a rare form of benign pure ovarian stromal tumour, derived from the ovarian sex cord stroma. It usually occurs unilaterally in young women and can be clinically, radiologically and morphologically eluting. Accurate diagnosis requires thorough pathological studies, both by morphology and immunohistochemistry. The main modality of treatment is surgical resection and clinical follow-up.

1.2. Case Report: We report a case of a right ovarian SST in a 26 years old lady, whom presented to the gynaecology clinic with a 45 days history of amenorrhea. Neither associated pain nor virilisation signs or symptoms at the time of presentation were found. Pelvic MRI revealed a 4.9 cm x 3.9 cm, mildly enlarged right ovary with a well-defined 4.1 cm x 3.4 cm x 4.0 cm area of abnormal signal intensity. On complimentary ultrasound, this ovarian lesion was isoechoic with internal arterial vascularity. Tumour markers (Ca 125, Ca 19-9, Ca 15-3) were all within the normal range. The patient underwent laparoscopic salpingo-oopherectomy and the detailed pathological studies were that of SST.

1.3. Conclusion: SSTs are generally considered to be rare. However, they should be thought of as a differential diagnosis when young patients present with menstrual irregularities, pelvic pain and when symptoms are refractory to conventional management.

Keywords:

Sclerosing stromal tumor; Ovary; Stromal-sex cord; Presentation; Adult patients

Citation:

Khalid Al-Sindi, Seena Al Mansoori, Fedaa Al-Sindi, Shaikha Isa Yateem, Omaima Ahmed. Ovarian Sclerosing Stromal Tumor, Incidental Discovery in a 26-Year-Old Female with a History of Amenorrhea. Jour of Onco Case Rep. 2022;2(1):1-10.